Tislelizumab-Lenvatinib Shows Promise for High-Risk Liver Cancer
In a groundbreaking advance that could redefine the therapeutic landscape for liver cancer, a new single-arm phase II clinical trial ...
In a groundbreaking advance that could redefine the therapeutic landscape for liver cancer, a new single-arm phase II clinical trial ...
In a groundbreaking advancement that could revolutionize cancer research and therapeutic development, a team of scientists led by Mocellin, Treillard, ...
As cancer treatment continuously evolves, immunotherapy remains at the forefront of transformative advances. At the 2025 Society for Immunotherapy of ...
In recent years, the landscape of cancer research has expanded significantly, particularly in understanding the intricate relationship between tumor cells ...
Cholesterol has long been implicated in cardiovascular diseases, but emerging research reveals its pivotal role in cancer progression, particularly colorectal ...
More than thirty years ago, the U.S. Food and Drug Administration (FDA) made a landmark decision by approving Bacillus Calmette-Guérin ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine